CY1107965T1 - Παρασκευασμα λεκτικων ιξου για στοματικη ληψη και μεθοδος - Google Patents

Παρασκευασμα λεκτικων ιξου για στοματικη ληψη και μεθοδος

Info

Publication number
CY1107965T1
CY1107965T1 CY20081100542T CY081100542T CY1107965T1 CY 1107965 T1 CY1107965 T1 CY 1107965T1 CY 20081100542 T CY20081100542 T CY 20081100542T CY 081100542 T CY081100542 T CY 081100542T CY 1107965 T1 CY1107965 T1 CY 1107965T1
Authority
CY
Cyprus
Prior art keywords
preparation
mistletoe
iii
mistletoe lectin
oral testing
Prior art date
Application number
CY20081100542T
Other languages
English (en)
Inventor
Ian Pryme
Original Assignee
Ian Pryme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ian Pryme filed Critical Ian Pryme
Publication of CY1107965T1 publication Critical patent/CY1107965T1/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Botany (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Ένα παρασκεύασμα για λήψη από το στόμα το οποίο αποτελείται βασικά από λεκτίνη I Ιξού (ML-I), λεκτίνη II Ιξού (ML-II) και λεκτίνη III Ιξού (ML-III), το οποίο ειδικότερα αποκλείει τις ενώσεις οι οποίες προκαλούν ναυτία που υπάρχουν σε εκχυλίσματα ιξού. Η εφεύρεση επίσης παρέχει μια μέθοδο παραγωγής του εν λόγω παρασκευάσματος, μία μέθοδο χρήσης του εν λόγω παρασκευάσματος για την παραγωγή φαρμακευτικών παρασκευασμάτων, και μία μέθοδο για χρήση του εν λόγω παρασκευάσματος στην αγωγή ασθενών οι οποίοι πάσχουν από καρκίνο και αυτοάνοσες νόσους.
CY20081100542T 2000-11-14 2008-05-26 Παρασκευασμα λεκτικων ιξου για στοματικη ληψη και μεθοδος CY1107965T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24795700P 2000-11-14 2000-11-14
EP01996387A EP1341811B9 (en) 2000-11-14 2001-11-12 Orally ingestible preparation of mistletoe lectins and method

Publications (1)

Publication Number Publication Date
CY1107965T1 true CY1107965T1 (el) 2013-09-04

Family

ID=22937047

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20081100542T CY1107965T1 (el) 2000-11-14 2008-05-26 Παρασκευασμα λεκτικων ιξου για στοματικη ληψη και μεθοδος

Country Status (13)

Country Link
US (1) US7550159B2 (el)
EP (1) EP1341811B9 (el)
JP (1) JP2004513926A (el)
KR (1) KR100832614B1 (el)
AT (1) ATE387209T1 (el)
AU (1) AU2120502A (el)
CY (1) CY1107965T1 (el)
DE (1) DE60133036T2 (el)
DK (1) DK1341811T3 (el)
ES (1) ES2301576T3 (el)
NZ (1) NZ526202A (el)
PT (1) PT1341811E (el)
WO (1) WO2002040041A2 (el)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60220068T2 (de) 2001-07-09 2008-01-24 University Of Copenhagen Verfahren und ableger für die massenvermehrung von pflanzenparasiten
KR101191081B1 (ko) 2008-05-19 2012-10-15 김종배 운동수행능력 증강 및 피로억제 효과를 갖는 겨우살이추출물
RU2644332C1 (ru) * 2016-12-30 2018-02-08 Общество с ограниченной ответственностью научно-технический центр "БиоКлиникум" (ООО НТЦ "БиоКлиникум") Способ получения растительного лектина ml1 из омелы белой и фармацевтическая композиция на его основе (варианты).

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4229876A1 (de) * 1992-09-04 1994-03-10 Uwe Dr Pfueller Verfahren zur Gewinnung von Lektinen aus Mistelpflanzen
DE4242902A1 (de) * 1992-12-18 1994-06-23 Madaus Ag Verfahren zur Herstellung von Lektinkonzentraten aus Mistelextrakten und daraus hergestellte standardisierte Präparate zur Erhöhung der natürlichen Immunresistenz und für die Verwendung in der Tumor-Therapie
US5595756A (en) * 1993-12-22 1997-01-21 Inex Pharmaceuticals Corporation Liposomal compositions for enhanced retention of bioactive agents
DE4421895A1 (de) * 1994-06-23 1996-01-04 Private Uni Witten Herdecke Gm Verfahren zur Isolierung von Isolektinen aus der Mistel
AU5532696A (en) * 1995-04-14 1996-10-30 University Of Southern California Mistletoe extract and method
EP0884388A1 (de) * 1995-06-26 1998-12-16 MADAUS AG Köln Transgene Pflanzen enthaltend rekombinantes Mistellektin (rML)
WO1997011967A1 (de) * 1995-09-27 1997-04-03 Thomas David Extrakt von viscum album (weisse mistel)
DE60045516D1 (de) * 1999-10-26 2011-02-24 Novartis Vaccines & Diagnostic Pflanzen lektine als mukosale adjuvantien

Also Published As

Publication number Publication date
WO2002040041A2 (en) 2002-05-23
JP2004513926A (ja) 2004-05-13
ATE387209T1 (de) 2008-03-15
DK1341811T3 (da) 2008-06-30
WO2002040041A3 (en) 2002-07-25
EP1341811B9 (en) 2008-11-05
EP1341811B1 (en) 2008-02-27
KR20030066664A (ko) 2003-08-09
KR100832614B1 (ko) 2008-05-27
US7550159B2 (en) 2009-06-23
DE60133036D1 (de) 2008-04-10
EP1341811A2 (en) 2003-09-10
NZ526202A (en) 2005-08-26
PT1341811E (pt) 2008-06-04
DE60133036T2 (de) 2009-04-02
ES2301576T3 (es) 2008-07-01
AU2120502A (en) 2002-05-27
US20040052869A1 (en) 2004-03-18

Similar Documents

Publication Publication Date Title
HUP0303800A2 (hu) Gyógyszerkészítmények, adagolási formák epotilonok orális beadására
GB0211649D0 (en) Organic compounds
ATE400573T1 (de) 1h-imidazochinolinderivate als proteinkinaseinhibitoren
CY1107838T1 (el) Παραγωγα αδαμαντανιου για τη θεραπεια φλεγμονωδων, ανοσολογικων και καρδιαγγειακων ασθενειων
PT1171143E (pt) Extracto peptidico de tremoco e composicao farmaceutica ou cosmetica ou nutraceutica compreendendo o referido extracto
WO2002102299A3 (en) Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer
HUP0402067A2 (hu) Oltóanyagok
DE60217090D1 (de) Amyloid plaque aggregationshemmer und diagnostische bilderzeugungsmittel
WO2002044324A3 (en) Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs
NO20064676L (no) Farmasoytiske salter av 3-0-(3'3'-dimetylsuccinyl)betulinsyre
UY27362A1 (es) Métodos de usar inhibidores de epóxido hidrolasa soluble
WO2002040702A3 (en) Methods for the treatment of cancer and other diseases and methods of developing the same
TW200616640A (en) Novel pharmaceutical formulations of active principles
WO2002094774A3 (en) Oxcarbazepine dosage forms
HUP0302874A2 (hu) Eljárás risperidon előállítására
HUP0102913A2 (hu) Biogén ösztrogén-szulfamátok alkalmazása hormonhelyettesítő terápiánál használható gyógyszerkészítmények előállítására
CY1107965T1 (el) Παρασκευασμα λεκτικων ιξου για στοματικη ληψη και μεθοδος
WO2003020214A3 (en) Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs
MXPA02011533A (es) Nuevas formulaciones de alfa-2,4-disulfofenil-n-terc-butilnitrona.
CY1107227T1 (el) Θεραπεια αυτοανοσων νοσων με εκχυλισμα αμερικανικου γκινσενγκ
DE60233936D1 (de) Therapeutische Zusammenseztungen zur Toleranzinduktion
ATE293445T1 (de) Herstellung reiner stereoisomere von tricyclo- (5.2.1.0(2.6) )-dec-9-yl-xanthogenat sowie deren verwendung als arzneimittel
HUP0301479A2 (hu) Cilansetron alkalmazása nemobstipációs férfi IBS-betegek kezelésére szolgáló gyógyszerkészítmény elżállítására
HUP9801236A2 (hu) Forskolin vagy ezt tartalmazó extraktum alkalmazása alkoholfüggőség kezelésére alkalmas gyógyszerkészítmény előállítására
IL153867A0 (en) Pharmaceutical preparation for the treatment and diagnosis of tumors and method for the preparation of the lipid free fraction of blood plasma